Andrew Mackie

Andrew Mackie formerly worked at Capsant Neurotechnologies Ltd., as Executive Chairman, Karus Therapeutics Ltd., as Non-Executive Director, Ergomed Plc, as Executive Director & Chief Business Officer from 2015 to 2018, Novartis, Inc., as Principal, Antisoma Research Ltd., as Head-Alliance Management, Sarossa Capital Ltd., as Head-Clinical Development, IP Group Plc, as Head-Life Sciences, MDS Co., Ltd., as Principal, Sanofi-Aventis Japan, as Principal, and Linklaters & Alliance.
Mr. Mackie received his undergraduate degree from Queen's University, graduate degree from the University of London, and Masters Business Admin degree from London Business School.